Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
AEMPS · 3 medicines
EMA · 3 medicines
AIFA · 3 medicines
CBG-MEB · 3 medicines
FDA · 3 medicines
ALIMS · 2 medicines
HSA · 1 medicine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
30 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Epysqli | United States | 300 mg/30 mL | injection | Marketed | Samsung Bioepis Co LTD |
| Bkemv | United States | 300MG/30ML | injectable | Marketed | Amgen INC |
| Soliris | United States | 300MG | injectable | Marketed | Alexion Pharm |
| Epysqli | European Union | Authorised | Samsung Bioepis NL B.V. | ||
| Herculiz | Brazil | Authorised | Bionovis S.A. - Companhia Brasileira de Biotecnologia Farmaceutica | ||
| Epysqli 300 MG Concentrado Para Solucion Para Perfusion | Spain | 300 mg | concentrado para solución para perfusión | Marketed | Samsung Bioepis Nl B.V. |
| Epysqli | Italy | Concentrato per soluzione per infusione | Authorised | Samsung Bioepis NL B.V. | |
| Bekemv | European Union | Authorised | Amgen Technology (Ireland) UC | ||
| Bekemv 300 MG Concentrado Para Solucion Para Perfusion | Spain | 300 mg | concentrado para solución para perfusión | Marketed | Amgen Europe B.V. |
| Soliris | European Union | Authorised | Alexion Europe SAS | ||
| SOLIRIS 300 mg CONCENTRADO PARA SOLUCION PARA PERFUSION | Spain | 300 mg | concentrado para solución para perfusión | Marketed | Alexion Europe Sas |
| Epysqli 300 mg concentraat voor oplossing voor infusie | Netherlands | Concentraat voor oplossing voor infusie | Authorised | Samsung Bioepis NL B.V. | |
| Bekemv | Italy | Concentrato per soluzione per infusione | Authorised | Amgen Europe B.V. | |
| BEKEMV 300 mg concentraat voor oplossing voor infusie | Netherlands | Concentraat voor oplossing voor infusie | Authorised | Amgen Europe B.V. | |
| Soliris | Italy | Concentrato per soluzione per infusione | Authorised | Alexion Europe S.A.S. | |
| Soliris, concentraat voor oplossing voor infusie 10 mg/ml (300 mg/30 ml) | Netherlands | Concentraat voor oplossing voor infusie | Authorised | Alexion Europe SAS | |
| Epysqli | Canada | 10 MG / ML | Solution | Authorised | Samsung Bioepis Co., LTD |
| Epysqli | Brazil | Authorised | Samsung Bioepis br Pharmaceutical ltda. | ||
| Soliris | Canada | 10 MG / ML | Solution | Marketed | Alexion Pharma GMBH |
| Bekemv | Brazil | Authorised | Amgen Biotecnologia do Brasil Ltda. | ||
| Soliris | Brazil | Authorised | Astrazeneca do Brasil Ltda | ||
| Soliris Concentrate for Solution for Infusion 300mg/vial | Singapore | 300 mg / vial | infusion, solution concentrate | Authorised | Astrazeneca Singapore Pte LTD |
| Soliris® | Serbia | 300mg | koncentrat za rastvor za infuziju | Authorised | PredstavniŠTvo Astrazeneca UK Limited Beograd |
| Soliris® | Serbia | 300mg | koncentrat za rastvor za infuziju | Authorised | PredstavniŠTvo Astrazeneca UK Limited Beograd |
| Epysqli | Croatia | Authorised |
The same brand on several registers.
The companies holding its medicines, the most first.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, Anvisa, CBG-MEB, EMA, FDA, HALMED, Health Canada and HSA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
